News

Portfolio Companies
in the News

Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial

September 25, 2024

Neuros Medical Receives FDA Approval for the Altius® Direct Electrical Nerve Stimulation System

August 28, 2024

HistoSonics Raises $102 Million for Liver Cancer Treatment

August 15, 2024

Miach Orthopaedics Raises $20 Million in Series B Extension

April 2, 2024

ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study

February 6, 2024

Synergy Spine Solutions Announces $30M Financing

January 31, 2024

Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure

November 2, 2023

Contego Medical Announces One-Year Outcomes From The Performance II Carotid Stent Trial

November 1, 2023

Trinity Capital Inc. Provides $25 Million Growth Capital to Neuros Medical, Inc.

October 31, 2023

category

Medtech

Status

Current

headquarters

Halifax, Nova Scotia

website

Sound Blade Medical

Sound Blade Medical is a medical device company that is developing handheld ultrasound-guided histotripsy technology to treat a wide range of conditions. Histotripsy is a non-invasive, non-thermal ablation technology to selectively destroy tissue with unparalleled precision.

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.

category

MEDTECH

status

Exited/Public

headquarters

Redwood City, California

website

Gynesonics

Gynesonics is a medical device company committed to advancing women’s health by developing transcervical, uterus-preserving, incisionless technologies for diagnostic and therapeutic applications. The company’s Sonata system is the world’s first and only intrauterine fibroid ablation system clinically proven to reduce fibroid symptoms across a wide range of fibroid types, sizes, and uterine locations.